Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07522190 · ClinicalTrials.gov registry record · NA

Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism

A NA study, sponsored by Stanford University.

Not yet
Registry status
NA
Development phase
140
Enrollment target

NCT07522190: Clinical Trial NA study, sponsored by Stanford University.

NCT07522190 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07522190, a NA study, has not yet begun recruiting, sponsored by Stanford University.

NOT YET RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target

Study Summary

The goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and which children may benefit most from each treatment. Additionally, after completing either the ESDM or PRT, some participants who meet specific clinical criteria may be offered home-based Developmental Reciprocity Treatment (DRT). The study will include boys and girls 2 to 4 years 11 months old diagnosed with ASD. The main questions this study aims to answer are whether center-based ESDM and center-based PRT improve communication skills in young children with autism, and whether certain children respond better to one treatment approach than the other. Participants will be randomly assigned to either ESDM or PRT for 24 weeks in a center-based program, attend treatment session 4 days per week (\~3 hours/day), complete developmental and autism assessments at baseline, 12 weeks, and 24 weeks, have a parent participate in weekly parent training sessions, and complete follow-up assessments at weeks 36 and 48.

Interventions

  • BEHAVIORAL Early Start Denver Model (ESDM)
  • BEHAVIORAL Pivotal Response Treatment (PRT)
  • BEHAVIORAL Developmental Reciprocity Treatment (DRT)

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2027-01
Est. Completion 2037-01
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT07522190

The ClinicalTrials.gov registry entry for NCT07522190 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Early Start Denver Model (ESDM) is the first listed.

NCT07522190 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07522190 about?

NCT07522190 is a clinical study titled "Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism". The goal of this study is to compare two well-established early autism interventions, Early Start Denver Model (ESDM) and Pivotal Response Treatment (PRT), to better understand which approach is most effective for improving communication skills in young children with autism and which children may be...

What is the current status of trial NCT07522190?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2027-01. Estimated completion is 2037-01.

What interventions are being tested in trial NCT07522190?

The interventions under investigation include: Early Start Denver Model (ESDM) (BEHAVIORAL), Pivotal Response Treatment (PRT) (BEHAVIORAL), Developmental Reciprocity Treatment (DRT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07522190?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.